Skip to main content

Find Clinical Trials

Home
Conditions
Myelodysplastic Syndromes

Clinical trial condition

Myelodysplastic Syndromes

Explore clinical trials studying Myelodysplastic Syndromes. Study availability and eligibility vary by location and protocol.

1,361 public trials 239 recruiting studies

Refine in advanced search Browse all conditions

Myelodysplastic Syndromes trial results

Completed

Study of TLK199 HCl Liposomes for Injection in Myelodysplastic Syndrome

NCT00035867

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +1 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

The Angeles Clinic & Research Institute Los Angeles, California, United States

University of Chicago Chicago, Illinois, United States

Midwest Cancer Research Group Skokie, Illinois, United States

View Trial Details

Completed

A Randomized Trial of Antithymocyte Globulin Versus Cyclosporine to Treat the Cytopenia of Myelodysplastic Syndrome

NCT00001839

Conditions: Anemia, Bone Marrow Diseases, Hematologic Diseases, +2 more
Locations: Warren G. Magnuson Clinical Center (CC) Bethesda, Maryland, United States

View Trial Details

Completed

HLA-Mismatched Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematological Malignancies

NCT00001748

Conditions: Bone Marrow Diseases, Chronic Disease, Disease Attributes, +25 more
Locations: National Heart, Lung and Blood Institute (NHLBI) Bethesda, Maryland, United States

View Trial Details

Completed

A Randomized Trial of Recombinant Humanized Anti-IL-2 Receptor Antibody (Daclizumab) Versus Antithymocyte Globulin (ATG) to Treat the Cytopenia of Myelodysplastic Syndrome (MDS)

NCT00072969

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +1 more
Locations: National Heart, Lung and Blood Institute (NHLBI) Bethesda, Maryland, United States

View Trial Details

Completed

Leucovorin for the Treatment of 5 q Minus Syndrome

NCT00004997

Conditions: 5q Minus Syndrome, Anemia, Anemia, Refractory, +7 more
Locations: Warren G. Magnuson Clinical Center (CC) Bethesda, Maryland, United States

View Trial Details

Completed

Infusion of Specially Treated Umbilical Cord Stem Cells After Chemoradiation Treatment for Blood Cancers

NCT00089596

Conditions: Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Bone Marrow Diseases, +25 more
Locations: Loyola University Medical Center Maywood, Illinois, United States

Indiana University Cancer Center Indianapolis, Indiana, United States

Hackensack University Medical Center Hackensack, New Jersey, United States

Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Completed

Thalidomide at Low Dose for the Treatment of Patient With Myelodysplastic Syndromes - THAL-SMD-200

NCT00455910

Conditions: Anemia, Bone Marrow Diseases, Cytopenia, +3 more
Locations: CHU d'Angers Angers, France

CH d'Avignon Avignon, France

CH de la Cote Basque Bayonne, France

Hopital Avicenne Bobigny, France

View all 20 locations

View Trial Details

Completed

A Randomized Trial of Human Growth Hormone (hGH) vs Placebo in Intensively Treated Haemato-Oncology Patients.

NCT00300664

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Blood Protein Disorders, +23 more
Locations: Not specified

View Trial Details

Completed

Study of Allogeneic Bone Marrow Transplantation Following Cyclophosphamide and Radiotherapy in Patients With Myelodysplastic Syndrome and Acute Leukemia Related to Fanconi's Anemia

NCT00005892

Conditions: Anemia, Anemia, Aplastic, Anemia, Hypoplastic, Congenital, +33 more
Locations: Fairview University Medical Center Minneapolis, Minnesota, United States

View Trial Details

Completed

A Study to Access the Safety/Efficacy of Thalidomide in the Treatment of Anemia in Patients With Myelodysplastic Syndromes

NCT00050843

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +1 more
Locations: Scripps Cancer Center La Jolla, California, United States

Comprehensive Cancer Centers of the Desert Palm Springs, California, United States

Desert Hematology Oncology Medical Group INC Rancho Mirage, California, United States

Whittingham Cancer Center Norwalk, Connecticut, United States

View all 38 locations

View Trial Details